The US government's updated list of active and long-term regulations makes clear that FDA's' infamous generic labeling rule is officially dead, but also that electronic distribution of labeling information was in a sense reborn.
The White House Office of Management and Budget on Dec
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?